✦ LIBER ✦

P-1084 - Efficacy of long-acting injectable risperidone in delusional disorder: an open-label, naturalistic and prospective study

✍ Scribed by Gonzalez Rodriguez, A.; Molina Andreu, O.; Imaz Gurrutxaga, M.L.; Pons Villanueva, A.

Book ID: 122613093
Publisher: Elsevier Science
Year: 2012
Tongue: French
Weight: 66 KB
Volume: 27
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(12)75251-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P03-26 Survey of safety and efficacy of

P03-26 Survey of safety and efficacy of long-acting injectable risperidone in daily practice: An open-label, non-interventional prospective study

✍ Parellada, E.; Kouniakis, F.; Siurkute, A.; Schreiner, A.; Don, L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 48 KB

LONG-TERM SAFETY, TOLERABILITY AND EFFIC

LONG-TERM SAFETY, TOLERABILITY AND EFFICACY OF RISPERIDONE LONG-ACTING INJECTABLE AND ORAL ATYPICAL ANTIPSYCHOTICS IN SCHIZOPHRENIC PATIENTS: TWO YEAR NATURALISTIC STUDY

✍ Ibach, Bernd; Rabinowitz, Jonathan; Schreiner, Andreas; Hargarter, Ludger; Dieka 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 65 KB

P03-46 - Long-term safety, tolerability

P03-46 - Long-term safety, tolerability and efficacy of risperidone long-acting injectable and oral atypical antipsychotics in schizophrenic patients: two year naturalistic study

✍ Ibach, B.; Rabinowitz, J.; Schreiner, A.; Hargarter, L.; Diekamp, B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 34 KB

P03-21 Relapse prevention in schizophren

P03-21 Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable versus quetiapine: Randomized, long-term, open-label, clinical trial results (ConstaTRE)

✍ Gaebel, W.; Bergmans, P.; de Arce, R.; Rouillon, F.; Cordes, J.; Eriksson, L.; S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 French ⚖ 46 KB

Relapse Prevention in Schizophrenia and

Relapse Prevention in Schizophrenia and Schizoaffective Disorder with Risperidone Long-Acting Injectable vs Quetiapine: Results of a Long-Term, Open-Label, Randomized Clinical Trial

✍ Gaebel, Wolfgang; Schreiner, Andreas; Bergmans, Paul; de Arce, Rosario; Rouillon 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 486 KB

Safety and efficacy of long-acting injec

Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients

✍ Swapna Verma; Mythily Subramaniam; Edimansyah Abdin; Kang Sim; Alex Su; Nelson L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract The study aimed to evaluate the efficacy of long‐acting injectable risperidone (LAR) in Asian patients with schizophrenia spectrum disorders. Twenty‐five patients enrolled in this 6‐month open labelled study. They were switched from their current antipsychotic to LAR without a prior or